Covid-19 Expert Series

Analyzing the crisis and responding to its aftermath
WHAT ARE THE PATHS FORWARD AFTER THE CRISIS?

The AXA Research Fund Covid19 Task Force has assembled to provide insights and ways forward in response to the crisis.

Our top-tier scientists will provide their analysis through their expert lenses in areas such as geopolitics, economics, health systems and epidemiology.

MEET THE TASKFORCE

Lily-Fang_avatar_1424909466_edited.jpg
Guiso-Luigi_edited.jpg

Prof. Luigi Guiso

AXA Chair on Household Finance and Insurance, Einaudi, Italy

> More about Prof. Guiso

J_edited.jpg

Prof. Franck Courchamp

 AXA Chair on Biological Invasions,  Université Paris Saclay, France

> More about Prof. Courchamp

Dirk3_edited.jpg

Prof. Gerry Killeen

AXA Chair in Applied Pathogen Ecology, University of Cork, Ireland

> More about Prof. Killeen

saturno-pedro_edited_edited.jpg
Sarah-Pressman_edited.jpg

Prof. Sarah Pressman
AXA Award on Mental Health, UC Irvine, USA

> More about Prof. Pressman

Prof. Thomas Lukasiewicz

AXA Chair in Explainable AI in Healthcare, Oxford University, United Kingdom

> More about Prof. Lukasiewicz

LATEST CONTENT

Civic capital and social distancing: Evidence from Italians’ response to COVID-19

Social distancing slows the spread of COVID-19. In regions that adopt social distancing practices early (i.e. before receiving explicit stay-at-home guidelines from their governments), the virus can be contained more quickly. Using Italian data from phone location tracking of movements made by individuals after the pandemic began, this column finds sharper drops in mobility in areas with higher ‘civic capital’, suggesting that civic values can mediate the social distancing process.

Biodiversity at Risk : Preserving the Natural World for our Future

The AXA Research Fund has just launched its latest publication, with a collection of interviews, articles and desk research that discuss the critical nature of biodiversity, the interdependencies between nature, climate change, the economy and security, based on insights from AXA Research Fund supported scientists and biodiversity and climate change experts. The report also provides an overview of AXA’s commitments in the area of biodiversity loss mitigation and resilience strategies.

Environmental Factors and Host Microbiomes
Shape Host–Pathogen Dynamics

The review provides new perspectives that improve our understanding of disease dynamics and ecology by incorporating environmental factors and microbiomes into disease theory.

Dr Alison Gregory shares how we can support our loved ones, neighbours and colleagues during the covid-19 pandemic.

Modelling COVID-19

A simplified arithmetic modelling tools for predicting COVID-19 transmission dynamics and how it is likely to respond to different containment, delay or mitigation strategies.

Podcast: Origins and implications of the COVID-19 pandemic

In this AXA XL podcast, Dr. Keck, social anthropologist, discusses different cultural perspectives on what it means to be a human or an animal. He also explains how these differences affect the likelihood of a new infectious disease arising from a new pathogen, as well as how different cultures respond when an outbreak like the current COVID-19 pandemic occurs.

Origins and implications of the COVID-19 pandemicDr. Frédéric Keck
00:00 / 25:25

Antibody testing may be key to getting the healthy back to work

CNN interview with Dr Lily Fang: Antibody testing may be key to getting the healthy back to work.

OpenCovid19 Initiative

The AXAResearchFund supports a ground-breaking open research digital initiative, OpenCOVID-19, aimed at providing efficient, fast and low-cost solutions for prevention, diagnosis & treatment of the disease.

Pathogens

Pathogens differ in their virulence (how fast they multiply in a host and causing harm) and their pathogenicity (ability to produce pathologic changes or disease), both linked to spread and mortality rate.

Slowing the growth of epidemic is simply not enough

The approach taken to containment in Ireland thus far remains too tentative as many people will be infected without clinical symptoms, writes Gerry Killeen.

SUBSCRIBE TO THE AXA RESEARCH FUND'S LATEST INSIGHTS

COVID-19 EXPERT SERIES 2020